BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 4219757)

  • 1. Immunology of schistosomiasis.
    Bull World Health Organ; 1974; 51(6):553-95. PubMed ID: 4219757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunology of schistosomiasis].
    Bull World Health Organ; 1976; 54(1):19-66. PubMed ID: 827340
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
    Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R
    Trop Geogr Med; 1994; 46(4 Spec No):242-6. PubMed ID: 7825228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status and future prospects for a vaccine against schistosomiasis.
    Lebens M; Sun JB; Czerkinsky C; Holmgren J
    Expert Rev Vaccines; 2004 Jun; 3(3):315-28. PubMed ID: 15176948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Schistosoma japonicum egg granuloma.
    Warren KS; Boros DL; Hang LM; Mahmoud AA
    Am J Pathol; 1975 Aug; 80(2):279-94. PubMed ID: 1163631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lung model of schistosome immunity in mice.
    von Lichtenberg F; Sher A; McIntyre S
    Am J Pathol; 1977 Apr; 87(1):105-23. PubMed ID: 851162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological investigations on patients with schistosomiasis with special reference to circulating antigen.
    Madwar MA; Voller A
    Tropenmed Parasitol; 1977 Mar; 28(1):57-62. PubMed ID: 860325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
    Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
    Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistoma mansoni soluble egg antigens: determination of the stage and species specificity of their serologic reactivity by radioimmunoassay.
    Hamburger J; Pelley RP; Warren KS
    J Immunol; 1976 Nov; 117(5 Pt 1):1561-6. PubMed ID: 1033955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cell mediated immune responses against Schistosoma spindale in BALB/c mice.
    Prechatangkit B; Dhaliwal JS; Ambu S
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):170-5. PubMed ID: 7825008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predicted impact of immunosuppression upon population age-intensity profiles for schistosomiasis.
    Mitchell KM; Mutapi F; Woolhouse ME
    Parasite Immunol; 2008 Sep; 30(9):462-70. PubMed ID: 18522703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector functions of eosinophils in schistosomiasis.
    Capron M; Capron A
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():167-70. PubMed ID: 1343889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.
    James SL; Pearce EJ; Sher A
    J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mouse model of schistosome immunity.
    Smithers SR; Simpson AJ; Yi X; Omer-Ali P; Kelly C; McLaren DJ
    Acta Trop Suppl; 1987 Jun; 12():21-30. PubMed ID: 2442986
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunity in human schistosomiasis: hope for a vaccine].
    Kouriba B; Traore B; Diemert D; Thera MA; Dolo A; Tounkara A; Doumbo O
    Med Trop (Mars); 2010 Apr; 70(2):189-97. PubMed ID: 20486361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathology of experimental schistosome (S. Mansoni) egg granulomas in mice--possible defence mechanisms mediated by local immune complexes.
    De Brito T; Hoshino-Shimizu S; da Silva LC; Kanamura H; Costa CM; Pinto PS
    J Pathol; 1983 May; 140(1):17-28. PubMed ID: 6343568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.
    Dunne DW; Butterworth AE; Fulford AJ; Kariuki HC; Langley JG; Ouma JH; Capron A; Pierce RJ; Sturrock RF
    Eur J Immunol; 1992 Jun; 22(6):1483-94. PubMed ID: 1601036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosome circulating antigens (CSA) as a possible diagnostic parameter for active infections.
    Qian ZL; Wen HC
    Acta Leiden; 1983 Dec; 51():37-52. PubMed ID: 6433639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.